Ultragenyx Pharmaceutical | RARE - Market Capitalization


Ultragenyx Pharmaceutical reported $1.8B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Esperion Therapeutics USD 475M 410M Mar/2026
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Kyowa Hakko Kirin JPY 1.33T 120.11B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025